FORT LAUDERDALE, US – News Direct – 30 November 2021 – Exchange Listing, LLC announced that its client, Advanced Human Imaging (Advanced Human Imaging or “The Company”), a rapidly growing medical technology company has commenced its listing on the Nasdaq Capital Market (“Nasdaq”) with American Depositary Receipts (“ADR’s”).
Based in Perth, Australia, American Human Imaging, is a cutting-edge mHealth technology enterprise that uses artificial intelligence to make human scanning possible from a smartphone.
The Company’s ADRs commenced trading on NASDAQ on November 19th, 2021 under the ticker symbol, (NASDAQ: AHI). The pricing of the Company’s U.S. initial public offering of 1,000,000 units is at a price to the public of US$10.50 per unit. Each unit issued in the offering consisted of two American Depositary Shares (“ADSs”) and one warrant to purchase one ADS. Each ADS offered represents 7 ordinary shares of AHI. The warrants are exercisable immediately, and expires three years from the date of issuance and have an exercise price of US$5.52 per ADS. The ADSs and warrants are immediately separable and were issued separately. Gross proceeds from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, were approximately US$10.5 million.
The Company has granted the underwriters a 45-day option to purchase up to an additional 300,000 ADSs and/or up to an additional 150,000 warrants to purchase up to 150,000 ADSs at the public offering price, less underwriting discounts, and commissions.
“Exchange Listing was instrumental in our achieving a listing on Nasdaq, the world’s most prestigious platform for emerging growth companies,” said Vlado Bosanac. “Their guidance and knowledge was immensely valuable throughout the early stages of this complex process. This important step for AHI will allow us to increase liquidity and gain exposure for the Company with institutional and retail investors in the United States.”
“Clearly, Advanced Human Imaging has transformed a smartphone into a health risk assessment tool,” said Peter Goldstein, CEO, Exchange Listing. “The Company’s revolutionary technology can be used to assess and capture chronic disease risks or more simply track fitness goals in under one minute. There’s no doubt about the product’s innovation and tremendous U.S. market potential.”
Exchange Listing provides companies with cost-effective and efficient direct access to one-stop solutions in the strategic planning and implementation of listing and up-listing on senior exchanges such as the Nasdaq or NYSE. Focusing on company-specific structuring to meet listing requirements, Exchange Listing serves as the primary point of contact with the exchange, investment bankers and lawyers throughout the listing process. With extensive experience in investment banking, securities law, corporate governance and business management, Exchange Listing and its strategic partners facilitate clients’ listing and capital markets objectives.